Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Unlock the Secrets of Animals that Survive Freezing!
The North American wood frog Rana sylvatica can survive being frozen solid - no heartbeat, no brain activity...
Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?
Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...
Human placentophagy: What is the microbial composition of raw and processed placental tissue?
Placentophagy is gaining in popularity as supporters of this behavior claim it has the ability to improve...